Navigation Links
Nobel Spotlight on IVF Boosts Family Building Procedures
Date:10/13/2010

SEATTLE, Oct. 13 /PRNewswire/ -- With the Nobel prize for medicine awarded to Robert Edwards, the pioneer British biologist who developed in vitro fertilization (IVF) for humans, "any remaining doubts about the importance of 'test tube babies' that have lingered over the past 32 years ago should finally be put to rest," says Michael S. Opsahl, M.D., recently named one of "Washington State's Best Doctors" in Washington Magazine.

"IVF, once perceived as expensive and a last resort for infertile couples, is now considered a first-line infertility treatment because it works so well," said Opsahl of Northwest Center for Reproductive Sciences.

"I will never forget the birth of the first IVF baby July 25, 1978, because it was also my birthday and I had just graduated from med school. I was somewhat surprised by the paranoia that surrounded the birth," he said. "The idea of engineering super humans was far from our minds; curing infertility was foremost."

Later that year, Opsahl attended lectures by Professor Edwards and his partner, gynecologist Patrick Steptoe, now deceased. "It seemed to be almost science fiction—even for those of us in the field," he added.

"We will continue to have unresolved issues around rapidly changing scientific knowledge, especially with regard to assisted reproductive technologies, which sometimes elicit strong emotional opinions," he said. "In truth, we only proceed with thoughtful evidence-based steps. Best of all, long-term studies reassure us that IVF children are as healthy and intelligent as other children," Opsahl said.

Today, the national average for IVF success is approximately 30 percent, compared to 5 to 10 percent in the first decade of IVF. At NCRS, rates are 64 percent for women under 35; 48 percent for women 35 to 37; and 37 percent for women 38 to 40 (according to statistics collected during 2005-2009 for the Society for Assisted Reproductive Technology.)

About Northwest Center for Reproductive Sciences

With clinics in Kirkland and Seattle, NCRS is a partnership of senior physicians and scientists who have been honored with numerous accolades, such as Seattle Magazine's "Top Doctors." Senior staff members, including physicians, laboratory scientists and administrators, each possess over 20 years' experience in the reproductive medicine field. For additional information, visit http://www.nwreprosci.com.


'/>"/>
SOURCE Northwest Center for Reproductive Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene pioneers follow in Nobel footsteps
2. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
5. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
6. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
7. Thomson Reuters Predicts Nobel Laureates
8. Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements
9. Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel
10. BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge
11. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):